Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 5621–5640 of 17,529 recalls

May 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Liquid Antacid Extra Strength

The Issue: Labeling: Label lacks warning - Magnesium safety warning

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint

The Issue: Labeling: Label lacks warning - Magnesium safety warning

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· QuVa Pharma, Inc.

Recalled Item: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium

The Issue: Subpotent drug - Product did not contain drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets

The Issue: Product Mix Up: Lisinopril 10 mg tablets were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 28, 2020· AVKARE Inc.

Recalled Item: Lamotrigine Tablets

The Issue: Presence of Foreign Substance consistent with granules from

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 27, 2020· Pfizer Inc.

Recalled Item: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 27, 2020· Apotex Inc.

Recalled Item: Metformin Hydrochloride Extended-Release Tablets

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
May 26, 2020· Aurobindo Pharma USA Inc.

Recalled Item: Olanzapine Tablets

The Issue: Failed Impurities/ Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 26, 2020· Aurobindo Pharma USA Inc.

Recalled Item: Olanzapine Tablets

The Issue: Failed Impurities/ Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 26, 2020· UNICHEM PHARMACEUTICALS USA INC

Recalled Item: Clonidine Hydrochloride Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 26, 2020· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Lamotrigine Tablets

The Issue: Presence of Foreign Substance visually consistent with the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate

The Issue: Some bottles may contain mixed strengths of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 22, 2020· Acella Pharmaceuticals, LLC

Recalled Item: NP Thyroid 30

The Issue: Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
May 22, 2020· The Harvard Drug Group

Recalled Item: Doxycycline Hyclate Tablets

The Issue: Failed Dissolution Specification: The dissolution test at the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 22, 2020· Acella Pharmaceuticals, LLC

Recalled Item: NP Thyroid 90

The Issue: Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
May 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate

The Issue: Some bottles may contain mixed strengths of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 22, 2020· Acella Pharmaceuticals, LLC

Recalled Item: NP Thyroid 60

The Issue: Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
May 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate

The Issue: Some bottles may contain mixed strengths of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 19, 2020· Flexion Therapeutics, Inc.

Recalled Item: Zilretta (triamcinolone acetonide extended-release injectable suspension)

The Issue: Temperature Abuse: Product was stored at room temperature

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 19, 2020· American Health Packaging

Recalled Item: Doxycycline Hyclate Tablets

The Issue: Failed dissolution specification - dissolution results of 59%

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund